Clinical Trial Update: Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis [Phase 2]

View source ↗

Summary

This is a phase 2 neoadjuvant trial evaluating FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver metastases; the study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Cetuximab (cetuximab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Colorectal Cancer, Unresectable Liver Metastasis | Phase 2 | Status: COMPLETED